<DOC>
	<DOC>NCT00165386</DOC>
	<brief_summary>The purpose of this study is to target lesions of the prostate in the bone and to biopsy these lesions using MRI to identify the areas.</brief_summary>
	<brief_title>MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients</brief_title>
	<detailed_description>- This study involves a one-time, MRI-guided bone marrow biopsy. Prior to this procedure, patients will need to have a bone scan performed within the last three months and a PSA blood test drawn within one month of registration to the study. - Patients are also required to participate in the DFCI research study "Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer".</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologic diagnosis of prostate cancer Bone scan consistent with or suspicious of metastatic prostate cancer within last three months Platelet count &gt; 50,000/ul PT and aPTT &lt; 1.5 x control At least one week removed from taking aspirin or coumadin Currently participating in protocol "Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer" Devices incompatible to MR studies (e.g. pacemakers, ear implants, etc.)</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>MRI-guided bone marrow biopsy</keyword>
</DOC>